Nanalysis Scientific (CVE:NSCI) Stock Price Down 19.6% – Time to Sell?

Nanalysis Scientific Corp. (CVE:NSCIGet Free Report)’s stock price traded down 19.6% during mid-day trading on Saturday . The stock traded as low as C$0.18 and last traded at C$0.19. 802,183 shares traded hands during trading, an increase of 866% from the average session volume of 83,002 shares. The stock had previously closed at C$0.23.

Nanalysis Scientific Stock Performance

The firm’s 50 day simple moving average is C$0.24 and its 200-day simple moving average is C$0.27. The company has a market capitalization of C$20.95 million, a price-to-earnings ratio of -1.68 and a beta of -0.75. The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42.

About Nanalysis Scientific

(Get Free Report)

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.

Further Reading

Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.